Doç. Dr. ÇAĞDAŞ KALKAN

Yayın Ağı

Makaleler 51

1. Risk factors associated with adenocarcinoma development in gastric neuroendocrine tumors: A multicenter 10-year follow-up study

KALKAN Ç., Acehan F., Atay A., KARATAŞ A., Aksoy E., Kenarli K., et al.

JOURNAL OF INVESTIGATIVE MEDICINE , 2025 (SCI-Expanded, Scopus)

2. Unraveling the Mysteries of Autoimmune Gastritis

Soykan İ., ER R. E., Baykara Y., Kalkan Ç.

Turkish Journal of Gastroenterology , cilt.36, sa.3, ss.135-144, 2025 (SCI-Expanded, Scopus, TRDizin)

3. Clinical Features and Prognosis of Acute Cholangitis in Octogenarians: A Prospective Comparative Study

Comoglu M., Acehan F., Sahiner E. S., Kalkan Ç., Comoglu E., Yılmaz Y., et al.

Medicina (Lithuania) , cilt.60, sa.11, 2024 (SCI-Expanded, Scopus)

4. Improved outcomes in patients with non-variceal upper gastrointestinal bleeding while undergoing antithrombotic therapy: A propensity score matching analysis

Acehan F., Karsavuranoğlu B., Aslan M., Kalkan Ç., Sahiner E. S., Inan O., et al.

Digestive and Liver Disease , cilt.56, sa.11, ss.1854-1862, 2024 (SCI-Expanded, Scopus)

5. Red cell distribution width-to-albumin ratio is a simple promising prognostic marker in acute cholangitis requiring biliary drainage

Acehan F., Camli H., Kalkan Ç., Tez M., Demir B. F., Altiparmak E., et al.

Hepatobiliary and Pancreatic Diseases International , cilt.23, sa.5, ss.487-494, 2024 (SCI-Expanded, Scopus)

6. Mide İçi Botulinum Toksini Enjeksiyonunun Obezite Tedavisindeki Başarısında Helicobacter pylori Pozitifliği Bir Faktör müdür?

HAMAMCI M., KENARLI K., KÖSEOĞLU H. T., AKBAY A., ERDOĞAN Ç., MACİF A., et al.

Akademik Gastroenteroloji Dergisi , cilt.23, 2024 (TRDizin)

7. Percutaneous Treatment of Hydatid Cysts with the Örmeci Technique

Ormeci N., ASİLLER Ö. Ö., Parmaksiz A., Kalkan Ç., ÜSTÜNER E., Altinel A., et al.

Turkish Journal of Gastroenterology , cilt.35, sa.5, ss.398-407, 2024 (SCI-Expanded, Scopus, TRDizin)

8. The role of endoscopic submucosal dissection in the treatment of large superficial duodenal epithelial neoplasia

BUYRUK A. M., BAKİ B. E., KALKAN Ç.

Akademik Gastroenteroloji Dergisi , cilt.23, sa.1, ss.6-12, 2024 (TRDizin)

9. The red cell distribution width-to-albumin ratio: A simple index has high predictive accuracy for clinical outcomes in patients with acute pancreatitis

Acehan F., Aslan M., Demir M. S., Koç Ş., Dügeroğlu B., Kalkan Ç., et al.

Pancreatology , cilt.24, sa.2, ss.232-240, 2024 (SCI-Expanded, Scopus)

10. Three Simple Parameters on Admission to the Emergency Department are Predictors for Endoscopic Intervention in Patients with Suspected Nonvariceal Upper Gastrointestinal Bleeding

Acehan F., Karsavuranoğlu B., Kalkan Ç., Aslan M., Altiparmak E., Ates I.

Journal of Emergency Medicine , cilt.66, sa.2, ss.64-73, 2024 (SCI-Expanded, Scopus)

11. Unveiling the link: Helicobacter pylori infection and impact on ischemia modified albumin, thiol, and disulfide levels

Yüksel M., Erdoǧan Ç., Köseoǧlu H. T., NEŞELİOĞLU S., Kenarli K., Akbay A., et al.

Turkish Journal of Biochemistry , 2024 (SCI-Expanded, Scopus)

12. Intragastric injection of botulinum toxin in the treatment of obesity: a single-center study

Köseoğlu H. T., Kenarlı K., AKBAY A., ERDOĞAN Ç., MACİF A., Göktaş M. D., et al.

Therapeutic Advances in Gastrointestinal Endoscopy , cilt.17, 2024 (ESCI)

13. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta

Kalkan Ç., Yılmaz Y., DOĞANAY B., SAVAŞ B., TUNÇ E., Çalışkan A., et al.

Journal of Viral Hepatitis , cilt.30, sa.5, ss.406-416, 2023 (SCI-Expanded, Scopus)

14. Characteristics and clinical outcomes of acute cholangitis in older patients

Acehan F., Çamlı H., Kalkan Ç., Tez M., Altiparmak E., Ates I.

European Geriatric Medicine , cilt.14, sa.2, ss.263-273, 2023 (SCI-Expanded, Scopus)

15. Revisiting the Ranson score in acute pancreatitis: Is the drop in hematocrit a worrisome sign?

Acehan F., Tez M., Kalkan Ç., Akdogan M., Altiparmak E., Doganay M., et al.

Journal of Hepato-Biliary-Pancreatic Sciences , cilt.30, sa.3, ss.315-324, 2023 (SCI-Expanded, Scopus)

16. Similarities and Differences Between Gerontal and Young Patients with Acute Pancreatitis: Evaluation of Clinical Characteristics and Outcomes

Kalkan E. A., Kalkan Ç., Kaçar S., Barutçu S., Yüksel M., Türker Ö. G., et al.

Turkish Journal of Gastroenterology , cilt.33, sa.10, ss.874-884, 2022 (SCI-Expanded, Scopus, TRDizin)

17. Prevalence and Determinants of Gastrointestinal Manifestations in Patients with Selected Rheumatologic Diseases

Kalkan E. A., Kalkan Ç., Barutcu S., KÜÇÜKŞAHİN O., Güçbey Ö., Köseoğlu T., et al.

Turkish Journal of Gastroenterology , cilt.33, sa.7, ss.576-586, 2022 (SCI-Expanded, Scopus, TRDizin)

18. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

Yurdaydin C., Keskin O., TUNÇ E., Çalişkan A., Önem S., Karakaya F., et al.

Hepatology , cilt.75, sa.6, ss.1551-1565, 2022 (SCI-Expanded, Scopus)

19. Histopathology of non-coeliac gluten sensitivity

KIRMIZI B. A., Salman F. G., SAVAŞ B., Kalkan Ç., Soykan I., ENSARİ A.

Virchows Archiv , cilt.480, sa.2, ss.315-322, 2022 (SCI-Expanded, Scopus)

20. Prevalence and predictors of colonoscopic findings in patients with autoimmune gastritis

Asfuroglu Kalkan E., Kalkan Ç., GÜMÜŞSOY M., Gucbey O., Soykan I.

Journal of Investigative Medicine , cilt.70, sa.1, ss.73-78, 2022 (SCI-Expanded, Scopus)

21. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.

Ozbas B., KESKİN O., Hecker H., Karahan I., Ozbas C., Kalkan Ç., et al.

Hepatology international , cilt.15, sa.6, ss.1442-1455, 2021 (SCI-Expanded, Scopus)

22. Clinical significance of concomitant extrahepatic autoimmune disease in patients with autoimmune liver disease

KARAKAYA M. F., ÖZTEKİN Ş., ÖZTÜRK Y., KALKAN Ç., MELEKOĞLU ELLİK Z., ELHAN A. H., et al.

Hepatology forum , 2021 (Hakemli Dergi)

23. Thiol/disulfide homeostasis and ischemia modified albumin levels in autoimmune gastritis and their relations with gastric emptying

Asfuroğlu Kalkan E., Boz S., EREL Ö., NEŞELİOĞLU S., Kalkan Ç., Soykan İ.

Turkish Journal of Medical Sciences , cilt.50, sa.1, ss.163-170, 2020 (SCI-Expanded, Scopus, TRDizin)

24. Discriminant value of IEL counts and distribution pattern through the spectrum of gluten sensitivity: a simple diagnostic approach

KIRMIZI B. A., Kalkan Ç., YÜKSEL S., Gencturk Z., SAVAŞ B., Soykan İ., et al.

Virchows Archiv , cilt.473, sa.5, ss.551-558, 2018 (SCI-Expanded, Scopus)

25. Percutaneous treatment with the Örmeci technique for hydatid disease located in the spleen: Single center experience for twenty six years

Ormeci N., Kalkan Ç., Karakaya F., ERDEN G. A., KÖSE S. K., Tüzün A. E., et al.

Turkish Journal of Gastroenterology , cilt.29, sa.5, ss.566-573, 2018 (SCI-Expanded, Scopus, TRDizin)

26. The Relations Among Serum Ghrelin, Motilin and Gastric Emptying and Autonomic Function in Autoimmune Gastritis

Kalkan Ç., Soykan I.

American Journal of the Medical Sciences , cilt.355, sa.5, ss.428-433, 2018 (SCI-Expanded, Scopus)

27. Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study

Yurdaydin C., Keskin O., Kalkan Ç., Karakaya F., Çalişkan A., Karatayli E., et al.

Hepatology , cilt.67, sa.4, ss.1224-1236, 2018 (SCI-Expanded, Scopus)

28. Interferon Treatment Duration in Patients with Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Yurdaydin C., Keskin O., Kalkan Ç., Karakaya F., Çalişkan A., Kabaçam G., et al.

Journal of Infectious Diseases , cilt.217, sa.8, ss.1184-1192, 2018 (SCI-Expanded, Scopus)

29. Utility of a laboratory score in the prediction of gastric emptying in autoimmune gastritis patients

Kalkan Ç., Soykan I.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.73, sa.1, ss.75-79, 2018 (SCI-Expanded, Scopus)

30. Utility of a laboratory score in the prediction of altered autonomic nervous system function in autoimmune gastritis

Kalkan Ç., Soykan I.

Turkish Journal of Gastroenterology , cilt.29, sa.1, ss.32-35, 2018 (SCI-Expanded, Scopus, TRDizin)

31. Utility of three prognostic risk scores in predicting outcomes in elderly non-malignant patients after percutaneous gastrostomy

Kalkan Ç., Kartal A., Karakaya F., Tüzün A., Soykan I.

Journal of Nutrition, Health and Aging , cilt.21, sa.10, ss.1344-1348, 2017 (SCI-Expanded, Scopus)

32. Similarities and differences between older and young adult patients with celiac disease

Kalkan Ç., Karakaya F., Soykan I.

Geriatrics and Gerontology International , cilt.17, sa.11, ss.2060-2067, 2017 (SCI-Expanded, SSCI, Scopus)

33. Rare But Life-Threatening Complication of Hydatid Disease

KARAKAYA M. F., KALKAN Ç., KARAKAYA M., ÖRMECİ N.

TÜRKIYE PARAZITOLOJII DERGISI / TÜRKIYE PARAZITOLOJI DERNEGI = ACTA PARASITOLOGICA TURCICA / TURKISH SOCIETY FOR PARASITOLOGY , cilt.41, sa.3, ss.180-182, 2017 (Scopus, TRDizin)

34. The association between gastroesophageal flap valve function and gastroesophageal reflux symptoms

Keskin O., Kalkan Ç., YAMAN A., Tüzün A., Soykan I.

Acta gastro-enterologica Belgica , cilt.80, sa.4, ss.471-475, 2017 (SCI-Expanded, Scopus)

35. Differences between older and young patients with autoimmune gastritis

Kalkan Ç., Soykan I.

Geriatrics and Gerontology International , cilt.17, sa.7, ss.1090-1095, 2017 (SCI-Expanded, SSCI, Scopus)

36. Comparison of three scoring systems for risk stratification in elderly patients wıth acute upper gastrointestinal bleeding

Kalkan Ç., Soykan I., Karakaya F., Tüzün A., Gençtürk Z. B.

Geriatrics and Gerontology International , cilt.17, sa.4, ss.575-583, 2017 (SCI-Expanded, SSCI, Scopus)

37. Investigation of glucocorticoid receptor and calpain-10 gene polymorphisms in Turkish patients with type 2 diabetes mellitus

Bayramci N. S., AÇIK L., Kalkan Ç., YETKİN İ.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.5, ss.1568-1575, 2017 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

38. Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up

Karakaya F., Özer S., Kalkan Ç., Tüzün E. A., Çalışkan A., Keskin O., et al.

Antiviral Therapy , cilt.22, sa.7, ss.559-570, 2017 (SCI-Expanded, Scopus)

39. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN R., Akyildiz M., Keskin O., Gungor G., Yilmaz T. U., Kalkan Ç., et al.

Clinical Transplantation , cilt.30, sa.10, ss.1216-1221, 2016 (SCI-Expanded, Scopus)

40. Anti-TNF-α agents and serum lipids in inflammatory bowel diseases

Kalkan Ç., Karakaya F., TÖRÜNER M., Çetinkaya H., Soykan I.

Clinics and Research in Hepatology and Gastroenterology , cilt.40, sa.4, 2016 (SCI-Expanded, Scopus)

41. Polyautoimmunity in autoimmune gastritis

Kalkan D., Soykan I.

European Journal of Internal Medicine , cilt.31, ss.79-83, 2016 (SCI-Expanded, Scopus)

42. Assessment of Gastric Emptying in Patients with Autoimmune Gastritis

Kalkan Ç., Soykan I., SOYDAL Ç., ÖZKAN E., Kalkan E.

Digestive Diseases and Sciences , cilt.61, sa.6, ss.1597-1602, 2016 (SCI-Expanded, Scopus)

43. Relationships between autonomic nerve function and gastric emptying in patients with autoimmune gastritis

Kalkan Ç., SOYDAL Ç., ÖZKAN E., Maden A., Soykan I.

Clinical Autonomic Research , cilt.26, sa.3, ss.189-196, 2016 (SCI-Expanded, Scopus)

44. Factors related to low serum vitamin B12 levels in elderly patients with non-atrophic gastritis in contrast to patients with normal vitamin B12 levels

Kalkan Ç., Karakaya F., Tüzün A., Gençtürk Z. B., Soykan I.

Geriatrics and Gerontology International , cilt.16, sa.6, ss.686-692, 2016 (SCI-Expanded, SSCI, Scopus)

45. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis

Kalkan Ç., Karakaya F., Şoykan I.

Turkish Journal of Gastroenterology , cilt.27, sa.6, ss.515-520, 2016 (SCI-Expanded, Scopus, TRDizin)

46. Impact of Periampullary Diverticula onBile Duct Stones and Ampullary Carcinoma

ÖRMECİ N., DEDA X., KALKAN Ç., TÜZÜN A. E., KARAKAYA M. F., DÖKMECİ A., et al.

Euroasian Journal of Hepato-Gastroenterology , cilt.6, sa.1, ss.31-34, 2016 (Hakemli Dergi)

47. Classification chaos in coeliac disease: Does it really matter?

Ozakinci H., Kirmizi A., SAVAŞ B., Kalkan Ç., Soykan I., ÇETİNKAYA H., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.212, sa.12, ss.1174-1178, 2016 (SCI-Expanded, Scopus)

48. Tenofovir - Best hope for treatment of chronic hepatitis B infection?

Örmeci N., Özbaş B., GÜNER H. R., Özkan H., Yalçi A., Çoban Ş., et al.

Turkish Journal of Gastroenterology , cilt.26, sa.4, ss.322-327, 2015 (SCI-Expanded, Scopus, TRDizin)

49. The predictive value of mean platelet volume, plateletcrit and red cell distribution width in the differentiation of autoimmune gastritis patients with and without type i gastric carcinoid tumors

Tüzün A., Keskin O., Yakut M., Kalkan Ç., Soykan I.

Platelets , cilt.25, sa.5, ss.363-366, 2014 (SCI-Expanded, Scopus)

50. Manometric assessment of esophageal motor function in patients with primary biliary cirrhosis

Bektas M., Seven G., İDİLMAN R., Yakut M., DOĞANAY B., Kabacam G., et al.

European Journal of Internal Medicine , cilt.25, sa.3, ss.230-234, 2014 (SCI-Expanded, Scopus)

51. The Risk of Ileocolonic Perforation in Patients with Behçets Disease: Report of Three Cases and Review of the Literature

BEKTAŞ M., KALKAN Ç., SOYKAN A. İ., BOYVAT A., SAVAŞ B., GEÇİM İ. E., et al.

Journal of Gastrointestinal &amp; Digestive System , cilt.4, 2014 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 33

1. The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis

KESKİN O., KALKAN Ç., ÖZTÜRK B., ÇALIŞKAN KARTAL A., ŞAHİN H., GÜMÜŞSOY M., et al.

EASL 2023, VİYANA, Avusturya, 21 Haziran 2023, (Özet Bildiri)

2. Yaşlı ve Genç Crohn Hastaları Arasındaki Klinik Benzerlikler ve Farklar

KALKAN Ç.

GASTROENTEROLOJİ GÜNLERİ, Ankara, Türkiye, 28 - 29 Şubat 2020, (Özet Bildiri)

3. ETIOLOGY OF CIRRHOSIS CHANGING TRENDS OVER THE YEARS: A SINGLE-CENTER TURKISH EXPERIENCE

İDİLMAN R., ÇALIŞKAN KARTAL A., AYDOĞAN M., KARAKAYA M. F., KALKAN Ç., ÖNEM S., et al.

DDW 2019, 19 - 21 Mayıs 2019, (Özet Bildiri)

4. 10 YILLIK PROSPEKTİF ÇALIŞMADA DÜŞÜK VİRAL YÜKLÜ HBV TAŞIYICILARI REAKTİVASYONDAN ZİYADE HBSAG KAYBETMEYE YATKINDIR.

KESKİN O., YAKUT M., YURDCU E., KALKAN Ç., AGAYEVA S., YILMAZ Y., et al.

12. ULUSAL HEPATOLOJİİ KONGRESİ, Antalya, Türkiye, 1 - 05 Mayıs 2019, (Özet Bildiri)

5. Nonnvasve Fbross Scores Are Not Useful for Predcton of Response to Treatment n Chronc Delta Hepatts

KESKİN O., YURDCU E., KALKAN Ç., ÇALIŞKAN KARTAL A., ELLİK Z., BOZDAYI A. M., et al.

AASLD LIVER MEETING 2018, San-Francisco, Kostarika, 9 - 13 Kasım 2018, (Özet Bildiri)

6. 18- FDG Positron Emisyon Tomografisinde İnsidental Gastrointestinal Sistem Tutulumlarının Klinik ve Endoskopik Önemi

KARAKAYA M. F., SOYDAL Ç., ÇALIŞKAN KARTAL A., KARAKAYA M., KALKAN Ç., SOYKAN A. İ.

34. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 1 - 06 Aralık 2017, (Özet Bildiri)

7. UTILITY OF MEAN PLATELET VOLUME, PLATELETCRIT,PLATELET-LYMPHOCYTE RATIO AND NEUTROPHILLYMPHOCYTE RATIO IN THE DIFFERENTIATION OF COLONCANCER AND COLONIC POLYPS IN OLDER PATIENTS

KARAKAYA M. F., KALKAN Ç., SOYKAN A. İ.

25th United European Gastroenterology WeekBarcelona 2017, BARSELONA, İspanya, 28 Ekim - 01 Kasım 2017, (Özet Bildiri)

8. In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellularcarcinoma development than chronic hepatitis B

KESKİN O., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., YURDAYDIN S. C.

THE INTERNATIONAL LIVER CONGRESS EASL 2017, Amsterdam, Hollanda, 19 - 23 Nisan 2017, (Özet Bildiri)

9. The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

YURDAYDIN S. C., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KESKİN O., et al.

EASL 2017, 20 Nisan 2017, (Özet Bildiri)

10. In patients under treatment, chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B

KESKİN O., İDİLMAN R., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., YURDAYDIN C.

THE INTERNATIONAL LIVER CONGREES 2017, 19 Nisan 2017, (Özet Bildiri)

11. Hepatoselüler Kanser Gelişiminde Kronik Hepatit D, Hepatit B’ ye Göre Daha Büyük Risk Faktörüdür.

KESKİN O., KARAKAYA M. F., KALKAN Ç., ÇALIŞKAN KARTAL A., İDİLMAN R., YURDAYDIN S. C.

33.ULUSAL GASTROENTEROLOJİ HAFTASI, Türkiye, 22 - 27 Kasım 2016, (Özet Bildiri)

12. The predictive value of ferritin in older patients in the diagnosis of colon cancer

KARAKAYA M. F., KALKAN Ç., TURAN D., ÇALIŞKAN KARTAL A., SOYKAN A. İ.

FALK SYMPOSIUM 2015, LUCERNE, İsviçre, 21 - 22 Ekim 2016, (Özet Bildiri)

13. Hepatitis Delta Virus Kinetics under the Prenylation Inhibitor Lonafarnib Suggest HDV-Mediated Suppression of HBV Replication

YURDAYDIN C., BOROCHOV N., KALKAN Ç., DEBROY S., KARATAYLI E., WİLLİAMS H., et al.

EASL 2016, 15 Nisan 2016, (Özet Bildiri)

14. Minimal Hepatik Ensefalopati Tanısında Kullanılan Psikometrik Testlerde Türkiye Normal Değerlerinin Belirlenmesi ve Kompanze Sirozlu Hastalarda Minimal Hepatik Ensefalopati Prevalansının Araştırılması

ÖZBAŞ B., KARAHAN İ., KALKAN Ç., KARAKAYA M. F., TÜZÜN A. E., GÜNŞAR F., et al.

32. ULUSAL GASTROENTEROLOJİ HAFTASI, Türkiye, 25 - 29 Kasım 2015, (Özet Bildiri)

15. ERAP1 gene polymorphisms in Turkish patients with inflammatory bowel disease and ankylosing spondylitis

ÇETİNKAYA H., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KÜÇÜKŞAHİN O., BEKTAŞ M., et al.

FALK SYMPOSIUM 2015 FREİBURG, Freiburg, Almanya, 16 - 17 Ekim 2015, (Özet Bildiri)

16. Health quality and sexual dysfunction in Turkish IBD patient

TÖRÜNER M., ATEŞ E., KALKAN Ç., KARAKAYA M. F., ÇETİNKAYA H., SOYKAN A. İ.

FALK SYMPOSIUM 2015 FREİBURG, Freiburg, Almanya, 16 - 17 Ekim 2015, (Özet Bildiri)

17. Etiology and Natural Course of End-Stage Liver Disease in the Real World Setting

DEDA X., KALKAN Ç., KESKİN O., TÜZÜN A. E., YAKUT M., KILIÇ G., et al.

DDW 2015, Washington, Kiribati, 16 - 19 Mayıs 2015, (Özet Bildiri)

18. OPTIMIZING THE PRENYLATION INHIBITOR LONAFARNIBUSING RITONAVIR BOOSTING IN PATIENTS WITH CHRONICDELTA HEPATITIS

YURDAYDIN S. C., İDİLMAN R., CHOONG I. S., KALKAN Ç., KESKİN O., KARAKAYA M. F., et al.

EASL - The International Liver Congress 2015, Vienna, Avusturya, 22 - 26 Nisan 2015, (Özet Bildiri)

19. Clinical significance of liver injury secondary to tumor necrosis factor-alpha antagonist therapy in patients with inflammatory bowel disease

KALKAN Ç., KARAKAYA M. F., ASFUROĞLU E., TÜZÜN A. E., TÖRÜNER M., ÇETİNKAYA H., et al.

FALK SYMPOSIUM 2015 FRANKFURT, Frankfurt, Almanya, 6 - 07 Mart 2015, (Özet Bildiri)